QuickMD notes that the DEA has temporarily placed mitragynine pseudoindoxyl, MGM-15, and MGM-16 into Schedule I while its separate process around 7-OH remains pending.
Published
Signal category
Legal & Regulatory
Quote
“DEA has temporarily placed mitragynine pseudoindoxyl, MGM-15, and MGM-16 into Schedule I, while its separate process around 7-OH remains pending.”
— QuickMD team
Company
QuickMD
Take control of your health with affordable, convenient telemedicine—available anytime, anywhere.
- Industry
- Hospitals and Health Care
- Location
- Santa Monica, US
- Company size
- 95 employees
QuickMD helps people take control of their health—anytime, anywhere. As a leading telemedicine provider, we deliver accessible, affordable, and convenient virtual care nationwide. Our network of licensed providers offers services including medication-assisted addiction treatment, weight loss, and urgent care without the hassle of waiting rooms or commutes. With more than 1 million patient visits completed, QuickMD is breaking down barriers to make high-quality healthcare available to everyone, wherever they are.
Founded 2019